BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36632137)

  • 1. Depletion of PSMD14 suppresses bladder cancer proliferation by regulating GPX4.
    Jia C; Zhang X; Qu T; Wu X; Li Y; Zhao Y; Sun L; Wang Q
    PeerJ; 2023; 11():e14654. PubMed ID: 36632137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deubiquitinase PSMD14 enhances hepatocellular carcinoma growth and metastasis by stabilizing GRB2.
    Lv J; Zhang S; Wu H; Lu J; Lu Y; Wang F; Zhao W; Zhan P; Lu J; Fang Q; Xie C; Yin Z
    Cancer Lett; 2020 Jan; 469():22-34. PubMed ID: 31634528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of Drp1 and enhancement of mitochondrial fission by the deubiquitinating enzyme PSMD14 facilitates the proliferation of bladder cancer cells.
    Song W; Li Z; Xia M; Xiao W
    Oncol Rep; 2024 Jan; 51(1):. PubMed ID: 37975230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of deubiquitinating enzyme PSMD14 overcomes chemoresistance in head and neck squamous cell carcinoma by antagonizing E2F1/Akt/SOX2-mediated stemness.
    Jing C; Duan Y; Zhou M; Yue K; Zhuo S; Li X; Liu D; Ye B; Lai Q; Li L; Yao X; Wei H; Zhang W; Wu Y; Wang X
    Theranostics; 2021; 11(6):2655-2669. PubMed ID: 33456565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deubiquitinase PSMD14 promotes ovarian cancer progression by decreasing enzymatic activity of PKM2.
    Sun T; Liu Z; Bi F; Yang Q
    Mol Oncol; 2021 Dec; 15(12):3639-3658. PubMed ID: 34382324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of human deubiquitinase PSMD14 induces cell cycle arrest and senescence.
    Byrne A; McLaren RP; Mason P; Chai L; Dufault MR; Huang Y; Liang B; Gans JD; Zhang M; Carter K; Gladysheva TB; Teicher BA; Biemann HP; Booker M; Goldberg MA; Klinger KW; Lillie J; Madden SL; Jiang Y
    Exp Cell Res; 2010 Jan; 316(2):258-71. PubMed ID: 19732767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting PSMD14 inhibits melanoma growth through SMAD3 stabilization.
    Yokoyama S; Iwakami Y; Hang Z; Kin R; Zhou Y; Yasuta Y; Takahashi A; Hayakawa Y; Sakurai H
    Sci Rep; 2020 Nov; 10(1):19214. PubMed ID: 33154524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deubiquitinating enzyme PSMD14 facilitates gastric carcinogenesis through stabilizing PTBP1.
    Li J; Li Y; Xu F; Sun B; Yang L; Wang H
    Exp Cell Res; 2022 Jun; 415(2):113148. PubMed ID: 35405117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The PSMD14 inhibitor Thiolutin as a novel therapeutic approach for esophageal squamous cell carcinoma through facilitating SNAIL degradation.
    Jing C; Li X; Zhou M; Zhang S; Lai Q; Liu D; Ye B; Li L; Wu Y; Li H; Yue K; Chen P; Yao X; Wu Y; Duan Y; Wang X
    Theranostics; 2021; 11(12):5847-5862. PubMed ID: 33897885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The deubiquitinating enzyme PSMD14 facilitates tumor growth and chemoresistance through stabilizing the ALK2 receptor in the initiation of BMP6 signaling pathway.
    Seo D; Jung SM; Park JS; Lee J; Ha J; Kim M; Park SH
    EBioMedicine; 2019 Nov; 49():55-71. PubMed ID: 31685442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deubiquitylase PSMD14 inhibits autophagy to promote ovarian cancer progression via stabilization of LRPPRC.
    Zhao Z; Xu H; Wei Y; Sun L; Song Y
    Biochim Biophys Acta Mol Basis Dis; 2023 Feb; 1869(2):166594. PubMed ID: 36328147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The proteasome component PSMD14 drives myelomagenesis through a histone deubiquitinase activity.
    He L; Yu C; Qin S; Zheng E; Liu X; Liu Y; Yu S; Liu Y; Dou X; Shang Z; Wang Y; Wang Y; Zhou X; Liu B; Zhong Y; Liu Z; Lu J; Sun L
    Mol Cell; 2023 Nov; 83(22):4000-4016.e6. PubMed ID: 37935198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of deubiquitinase PSMD14 in lung adenocarcinoma (LUAD) and its prognostic significance.
    Zhang L; Xu H; Ma C; Zhang J; Zhao Y; Yang X; Wang S; Li D
    J Cancer; 2020; 11(10):2962-2971. PubMed ID: 32226511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel insights into the non-canonical roles of PSMD14/POH1/Rpn11 in proteostasis and in the modulation of cancer progression.
    Bustamante HA; Albornoz N; Morselli E; Soza A; Burgos PV
    Cell Signal; 2023 Jan; 101():110490. PubMed ID: 36241058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deubiquitinating enzyme PSMD14 promotes tumor metastasis through stabilizing SNAIL in human esophageal squamous cell carcinoma.
    Zhu R; Liu Y; Zhou H; Li L; Li Y; Ding F; Cao X; Liu Z
    Cancer Lett; 2018 Apr; 418():125-134. PubMed ID: 29331416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic role of PSMD14 in head and neck squamous cell carcinoma.
    Schnoell J; Scheiflinger A; Al-Gboore S; Kadletz-Wanke L; Kenner L; Heiduschka G; Jank BJ
    J Cancer Res Clin Oncol; 2023 Jun; 149(6):2483-2490. PubMed ID: 35750900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hes-related family BHLH transcription factor with YRPW motif 1-activated proteasome 26S subunit, non-ATPase 14 regulates trophoblast function and endometrial angiogenesis.
    Zhang L; Zhang S; Chen F
    Exp Ther Med; 2022 Jul; 24(1):476. PubMed ID: 35761814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of PSMD14 as a potential novel prognosis biomarker and therapeutic target for osteosarcoma.
    Gong Y; Wei ZR
    Cancer Rep (Hoboken); 2022 Jul; 5(7):e1522. PubMed ID: 34383385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic value of USP14 and PSMD14 expression in non-small cell lung cancer.
    Lei J; Liu X; Liu W; Zhang Y; Liu Z
    Ann Transl Med; 2021 Jun; 9(12):1019. PubMed ID: 34277819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ECT2/PSMD14/PTTG1 axis promotes the proliferation of glioma through stabilizing E2F1.
    Zhi T; Jiang K; Xu X; Yu T; Zhou F; Wang Y; Liu N; Zhang J
    Neuro Oncol; 2019 Mar; 21(4):462-473. PubMed ID: 30590814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.